Yale Medicine School: Novel Gene Editing Platform To Correct Multi-Organ Cystic Fibrosis
October 06, 2022
October 06, 2022
NEW HAVEN, Connecticut, Oct. 6 (TNSjou) -- Yale School of Medicine issued the following news:
An interdisciplinary team of Yale researchers has developed a novel gene editing platform that has the potential to correct cystic fibrosis (CF), a potentially debilitating and deadly disease.
Cystic fibrosis is caused by a mutation in a gene called the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). It is often thought of as a lung disease because some of the most . . .
An interdisciplinary team of Yale researchers has developed a novel gene editing platform that has the potential to correct cystic fibrosis (CF), a potentially debilitating and deadly disease.
Cystic fibrosis is caused by a mutation in a gene called the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). It is often thought of as a lung disease because some of the most . . .